Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona
Environmental Research,
Journal Year:
2023,
Volume and Issue:
223, P. 115419 - 115419
Published: Feb. 4, 2023
There
is
wide,
largely
unexplained
heterogeneity
in
immunological
and
clinical
responses
to
SARS-CoV-2
infection.
Numerous
environmental
chemicals,
such
as
persistent
organic
pollutants
(POPs)
chemical
elements
(including
some
metals,
essential
trace
elements,
rare
earth
minority
elements),
are
immunomodulatory
cause
a
range
of
adverse
events.
no
prospective
studies
on
the
effects
substances
incidence
infection
COVID-19.To
investigate
influence
blood
concentrations
POPs
measured
several
years
before
pandemic
development
COVID-19
individuals
from
general
population.We
conducted
cohort
study
154
population
Barcelona.
were
samples
collected
2016-2017.
was
detected
by
rRT-PCR
nasopharyngeal
swabs
and/or
antibody
serology
using
eighteen
isotype-antigen
combinations
2020-2021.
We
analyzed
associations
between
contaminants
COVID-19,
taking
into
account
personal
habits
living
conditions
during
pandemic.Several
historically
prevalent
POPs,
well
arsenic,
cadmium,
mercury,
zinc,
not
associated
with
nor
However,
DDE
(adjusted
OR
=
5.0
[95%
CI:
1.2-21]),
lead
(3.9
[1.0-15]),
thallium
(3.4
[1.0-11]),
ruthenium
(5.0
[1.8-14])
tantalum,
benzo(b)fluoranthene,
DDD,
manganese.
Thallium
(3.8
[1.6-8.9]),
(2.9
[1.3-6.7])
infection,
so
lead,
gold,
(protectively)
iron
selenium.
identified
mixtures
up
five
groups,
all
independently
outcomes.Our
results
provide
first
population-based
evidence
an
association
individual
may
contribute
explain
population.
If
confirmed
causal,
means
available
mitigate
corresponding
risks.
Language: Английский
Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units
Experimental and Therapeutic Medicine,
Journal Year:
2024,
Volume and Issue:
27(2)
Published: Jan. 4, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS‑CoV‑2)
infection
and
the
resulting
disease
2019
(COVID‑19)
represented
a
global
public
health
crisis
most
significant
pandemic
in
modern
times.
Transmission
characteristics,
lack
of
effective
antiviral
treatment
protocol
protective
vaccines,
pushed
healthcare
systems,
particularly
intensive
care
units
(ICUs),
to
their
limits
led
extreme
quarantine
measures
control
pandemic.
It
was
evident
from
an
early
stage
that
patient
stratification
approaches
needed
be
developed
better
predict
progression.
In
present
study,
predictive
value
clinical
blood
biomarkers
for
outcomes
patients
with
COVID‑19
hospitalized
ICU
were
investigated,
taking
age
sex
into
consideration.
The
study
analyzed
samples
3,050
ICU.
analysis
revealed
levels
procalcitonin,
N‑terminal
pro‑B‑type
natriuretic
peptide,
D‑dimer,
ferritin,
liver
enzymes,
C‑reactive
protein
lactate
dehydrogenase
increased
associated
progression,
prolonged
hospitalization
period
severe
related
complications.
Additionally,
disparities
among
these
documented
discussed
specific
cases.
On
whole,
results
suggest
potential
association
demographic
characteristics
mortality
COVID‑19.
Language: Английский
Predictive Ability of Previous Pain and Disease Conditions on the Presentation of Post‐COVID Pain in a Danish Cohort of Adult COVID‐19 Survivors
European Journal of Pain,
Journal Year:
2025,
Volume and Issue:
29(5)
Published: April 5, 2025
ABSTRACT
Background
Even
though
many
post‐COVID
pain
risk
factors
have
been
identified,
little
is
known
about
the
predictive
profiles
of
these
for
development
pain.
Methods
Data
was
collected
from
two
separate
questionnaires
assessing
demographics,
pre‐existing
medical
comorbidities,
history,
and
experience.
Socioeconomic
data
COVID‐19
RT‐PCR
test
results
were
Danish
registries.
The
study
cohort
(
n
=
68,028)
stratified
into
groups
reporting
pre‐COVID
9090)
no
55,938).
Forward‐selection
prediction
models
employed
to
identify
predictor
in
full
(Model
1)
with
2)
without
3)
58
potential
factors.
Results
Model
1
achieved
a
5‐fold
cross‐validated
AUC
(cvAUC)
0.68.
Use
medication,
stress,
high
income,
age,
female
gender,
weight
top
predictors
contributing
97%
model
performance.
2
(cvAUC
0.69)
identified
use
breathing
pain,
height,
physical
activity,
as
98.6%
3
0.65)
weight,
higher
education,
activity
98.5%
Height
unique
2,
while
being
income
3.
Conclusions
highlights
important
predictors,
further
research
needed
describe
detail.
may
apply
understanding
post‐viral
sequelae
after
other
viral
infections.
Significance
Statement
explorative
investigates
ability
battery
potentially
associated
This
article
presents
interest
survivors
will
contribute
patient
that
might
develop
conditions
provide
first
step
towards
focused
clinical
research.
Language: Английский
Prepandemic personal concentrations of per- and polyfluoroalkyl substances (PFAS) and other pollutants: Specific and combined effects on the incidence of COVID-19 disease and SARS-CoV-2 infection
Environmental Research,
Journal Year:
2023,
Volume and Issue:
237, P. 116965 - 116965
Published: Aug. 29, 2023
Language: Английский
COVID-19-Osteoarthritis Interactions, Predictions, and Mitigation: Can Blue Zone Findings Help? Overview and Commentary
Acta Scientific Pharmaceutical Sciences,
Journal Year:
2023,
Volume and Issue:
unknown, P. 26 - 36
Published: Nov. 1, 2023
The
corona
virus-19
,
which
unexpectedly
heightened
multiple
health
challenges
among
older
adults
beginning
in
December
2019,
continues
to
influence
many
facets
of
elder
including
having
a
possible
role
exacerbating
osteoarthritis
linkages
or
combination
2023
and
possibly
beyond
this
period.At
the
same
time,
recent
2050
prevalence
predictions
that
may
well
be
underestimates
imply
any
effort
minimize
disability
must
highly
warranted
its
own
right,
because
is
major
risk
factor
for
severe
COVID-19
infections.Based
on
key
2022-2023
data
base
posting,
small
body
current
work
strengthens
case
our
view
more
elucidation
interpretation
clinical
significance
presently
alluded
not
overlook
what
has
been
learned
about
population
wellbeing
healthy
aging
from
both
pandemic
as
successes
Blue
Zone
locations.
Language: Английский
Circulating Microrna-146a as A Biomarker Related To Inflammation in Thalasemia Patients
Heba Hani Hamzah,
No information about this author
Nawal Khinteel Jabbar
No information about this author
Academia Open,
Journal Year:
2023,
Volume and Issue:
9(2)
Published: Oct. 11, 2023
This
study
delves
into
the
intricate
realm
of
microRNAs
(miRNAs),
non-coding
RNA
molecules
that
wield
significant
influence
in
pathogenesis
various
disorders.
With
advent
advanced
technologies,
accurate
quantification
miRNA
abundance
across
diverse
tissues
is
now
attainable.
Notably,
extracellular
circulating
microparticles
have
emerged
as
robust,
stable
indicators
for
blood-based
disease
diagnostics.
investigation
explores
dynamic
interplay
between
and
clinical
phenotypes,
offering
valuable
insights
intricacies.
The
research
narrows
its
focus
to
recent
developments
employing
biomarkers
prevalent
inflammatory
disorders,
including
infections
endemic
thalassemia
patients
city
Diwaniyah,
Iraq.
Current
findings
paint
a
promising
future
utilization
management
diseases.
In
conclusion,
this
comprehensive
exploration
miRNA's
regulatory
role
globin
gene
expression
has
potential
revolutionize
landscape
thalassemia,
ameliorating
manifestations
symptoms
debilitating
hemoglobinopathy.
identification
miRNAs
implicated
disease's
pathophysiology
not
only
paves
way
novel
diagnostic
markers
but
also
opens
new
horizons
therapeutic
interventions.
Highlights
:
MiRNA
Significance:
MicroRNAs
play
pivotal
mechanisms.
Circulating
Microparticles:
Extracellular
are
indicators,
holding
promise
diagnostics
management,
especially
context
Thalassemia
Insights:
highlights
impact
on
expression,
avenues
diagnosis
treatment
Keywords
Microparticles,
Thalassemia,
Inflammatory
Disorders,
Disease
Diagnostics
Language: Английский